ストックスクリーナーアプリを入手
1.53
15.04%
0.20
Citius Pharmaceuticals Inc (CTXR) 最新ニュース
Citius Oncology prepares for lymphoma treatment launch in 2025 By Investing.com - Investing.com Nigeria
Citius Oncology On Track to Launch Lymphir in US in H2 - MarketScreener
Citius Oncology prepares for lymphoma treatment launch in 2025 - Investing.com
Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025 - PR Newswire
Millennium Management LLC Sells 1,126,188 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World
Citius Oncology enters distribution services agreement with Cardinal Health - MSN
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - The Victoria Advocate
Citius Pharmaceuticals Closes $6M Securities Offering - TipRanks
After Major Oncology Conference, All Eyes Turn to Industry Innovation - Quantisnow
Citius Pharmaceuticals Announces Closing Of Registered Direct Offering Of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - MarketScreener
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules | CTXR Stock News - GuruFocus
Citius Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits - Quantisnow
Citius Pharmaceuticals Secures $15.8M Financing Deal: What This Means for LYMPHIR Commercialization - Stock Titan
Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - Longview News-Journal
Citius Pharmaceuticals (CTXR) Target Price Reduced Amid Fundrais - GuruFocus
Citius Pharma secures $6 million in stock offering By Investing.com - Investing.com South Africa
Citius Pharmaceuticals (CTXR) Target Price Reduced Amid Fundraising Efforts | CTXR Stock News - GuruFocus
Citius Pharmaceuticals Stock Is Falling Tuesday: What's Going On? - Benzinga
Citius Pharmaceuticals (CTXR) Announces $6 Million Direct Offeri - GuruFocus
Citius Pharmaceuticals (CTXR) Announces $6 Million Direct Offering - GuruFocus
Citius Pharmaceuticals (CTXR) Price Target Lowered, Rating Maint - GuruFocus
Citius Pharmaceuticals announces registered direct offering of $15.8 million - MSN
Citius Pharma secures $6 million in stock offering - Investing.com Australia
Citius Pharmaceuticals (CTXR) Announces Stock and Warrant Offeri - GuruFocus
Citius Pharmaceuticals (CTXR) Announces Stock and Warrant Offering | CTXR Stock News - GuruFocus
Citius Pharma Announces Direct Offering - Nasdaq
Citius Pharmaceuticals Announces a Registered Direct Offering of - GuruFocus
Citius Pharmaceuticals (NASDAQ:CTXR) Given “Buy” Rating at D. Boral Capital - Defense World
Citius Pharmaceuticals expands authorized shares By Investing.com - Investing.com Nigeria
Citius Oncology partners with Cardinal Health for LYMPHIR distribution By Investing.com - Investing.com South Africa
Citius Pharmaceuticals (CTXR) Receives Continued Buy Rating from Analyst | CTXR Stock News - GuruFocus
Citius Pharmaceuticals expands authorized shares - Investing.com
Citius Pharmaceuticals Stock Is Soaring Monday: What's Going On? - Benzinga
Citius Oncology Signs US Distribution Deal With Cardinal Health for Lymphir - marketscreener.com
Cardinal Health (CAH) Partners with Citius Oncology for LYMPHIR Distribution | CAH Stock News - GuruFocus
Citius Oncology Inks Distribution Services Agreement With Cardinal Health For LYMPHIR - Nasdaq
Citius Oncology stock soars on distribution deal By Investing.com - Investing.com South Africa
Citius Oncology stock soars on distribution deal - Investing.com Australia
Citius Oncology partners with Cardinal Health for LYMPHIR distribution - Investing.com
Citius Oncology Enters into Distribution Services Agreement with Cardinal Health | CTXR Stock News - GuruFocus
Citius Oncology Enters into Distribution Services Agreement with Cardinal Health - Yahoo Finance
Squarepoint Ops LLC Sells 609,711 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World
Northern Trust Corp Sells 306,583 Shares of Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) - Defense World
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update - mx.advfn.com
Citius Pharmaceuticals Issues $1M Promissory Note to Pagoda - TipRanks
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Receives $54.50 Consensus Price Target from Brokerages - Defense World
Why Shares of SoundHound AI Are Soaring Today - The Globe and Mail
Citius Pharmaceuticals (NASDAQ:CTXR) Cut to Hold at Maxim Group - Defense World
Maxim Group Downgrades Citius Pharmaceuticals (CTXR) - MSN
This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
Citius Pharmaceuticals (CTXR) Downgraded to Hold by Maxim Group - GuruFocus
1.11%
1.70%
大文字化:
|
ボリューム (24 時間):